Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children

Vladimir G Magalhães1, Sören Lukassen2, Maike Drechsler1

  • 1Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response", Division Virus-Associated Carcinogenesis (F170), German Cancer Research Center (DKFZ), Heidelberg, Germany.

EMBO Reports
|October 11, 2023
PubMed

Insights

Children exhibit remarkable resistance to severe COVID-19 due to a robust innate immune response. Their airway epithelial cells possess enhanced interferon responses, offering protection against SARS-CoV-2 infection.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Severe COVID-19 risk increases significantly with age.
  • Molecular mechanisms of age-dependent COVID-19 severity are not well understood.
  • Innate immunity, particularly interferon response, is crucial in primary viral infections.

Purpose of the Study:

  • To investigate the molecular mechanisms behind children's lower risk of severe COVID-19.
  • To understand the age-dependent differences in innate immune responses to SARS-CoV-2.
  • To explore the role of airway epithelial cells and immune cell interactions in pediatric resistance.

Main Methods:

  • Single-cell transcriptome analysis of nasal turbinate cells.
  • In vitro experiments using adolescent peripheral blood mononuclear cells and A549 cells.
  • Assessment of cytokine production and interferon responses.

Main Results:

  • Children show increased frequencies of immune cells in airways.
  • Enhanced cytokine-mediated interactions between immune and epithelial cells were observed.
  • Epithelial cells in children exhibit stronger expression of viral sensors (RIG-I, MDA5) via IRF1.
  • Adolescent immune cells prime epithelial cells for heightened interferon responses to SARS-CoV-2.

Conclusions:

  • Children's airways have heightened immune cell presence and enhanced cytokine signaling.
  • These factors prime the epithelial antiviral system, contributing to resistance against SARS-CoV-2.
  • Findings offer insights into the molecular basis of pediatric COVID-19 resistance and potential immunoprophylactic strategies.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
800
Cross-reactivity00:42

Cross-reactivity

Overview
31.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.6K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
512